Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
988
datasets available to search
ShareScore release 0.9.0
Dataset results
988 results for “platinum”
EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian Cancer
ClinicalTrials.gov study NCT05715216. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma
ClinicalTrials.gov study NCT00183794. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Pembrolizumab And Platinum With Radiotherapy in Cervix Cancer
ClinicalTrials.gov study NCT03144466. IPD Sharing: NO. Countries: 1. Publications: 0.
Apatinib and Etoposide Capsule Versus Weekly Paclitaxel in Patients With Platinum Resistant Ovarian Cancer
ClinicalTrials.gov study NCT04000295. IPD Sharing: NO. Countries: 1. Publications: 0.
Erlotinib and Standard Platinum-Based Chemotherapy for Newly Diagnosed, Advanced Non-Small Cell Carcinoma of the Lung
ClinicalTrials.gov study NCT00391586. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adjuvant Platinum and Taxane in Triple-negative Breast Cancer (PATTERN)
ClinicalTrials.gov study NCT01216111. IPD Sharing: Not stated. Countries: 0. Publications: 8.
PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer
ClinicalTrials.gov study NCT04493619. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Study of the Combination of ACP-196 and Pembrolizumab in Subjects With Platinum Resistant Urothelial Bladder Cancer
ClinicalTrials.gov study NCT02351739. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of CRS-207 With Epacadostat in Platinum Resistant Ovarian, Fallopian or Peritoneal Cancer
ClinicalTrials.gov study NCT02575807. IPD Sharing: NO. Countries: 2. Publications: 0.
Abemaciclib + Nivolumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed or Recurred Within Six Months After Platinum-based Chemotherapy
ClinicalTrials.gov study NCT03655444. IPD Sharing: NO. Countries: 1. Publications: 0.
A Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer with DNA Repair Defects
ClinicalTrials.gov study NCT04288687. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of Tobemstomig Plus Platinum-Based Chemotherapy vs Pembrolizumab Plus Platinum-Based Chemotherapy in Participants With Previously Untreated Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT05775289. IPD Sharing: YES. Countries: 11. Publications: 0.
A Study of Tiragolumab Plus Atezolizumab Compared With Placebo Plus Atezolizumab in Participants With Completely Resected Non-small Cell Lung Cancer Who Have Received Adjuvant Platinum-based Chemother
ClinicalTrials.gov study NCT06267001. IPD Sharing: YES. Countries: 11. Publications: 0.
Study of Pemetrexed+Platinum Chemotherapy With or Without Cosibelimab in First Line Metastatic Non-squamous NSCLC
ClinicalTrials.gov study NCT04786964. IPD Sharing: Not stated. Countries: 8. Publications: 0.
Nivolumab and Epacadostat With Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03348904. IPD Sharing: NO. Countries: 1. Publications: 0.
E7080 in Combination With Carboplatin + Gemcitabine Versus Carboplatin + Gemcitabine Alone as Second Line Therapy in Patients With Platinum-Sensitive Recurrent Ovarian Cancer by CA125
ClinicalTrials.gov study NCT01133756. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-b
ClinicalTrials.gov study NCT04463771. IPD Sharing: YES. Countries: 7. Publications: 0.
Berzosertib + Topotecan in Relapsed Platinum-Resistant Small-Cell Lung Cancer (DDRiver SCLC 250)
ClinicalTrials.gov study NCT04768296. IPD Sharing: YES. Countries: 7. Publications: 0.
Study of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian Cancer
ClinicalTrials.gov study NCT00719212. IPD Sharing: Not stated. Countries: 7. Publications: 0.
(PGA) for Platinum-resistant/Refractory, Paclitaxel-Pretreated Recurrent Ovarian and Peritoneal Carcinoma
ClinicalTrials.gov study NCT01936974. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.